Eyal Shamir - 02 Nov 2026 Form 4 Insider Report for IceCure Medical Ltd. (ICCM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Nov 2026, 16:30:21 UTC
Prior SEC filing
25 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Eyal Shamir
Filing notes and source

Key filing fact

Eyal Shamir filed Form 4 for IceCure Medical Ltd. (ICCM) on 02 Nov 2026.

Key facts

  • This page summarizes Eyal Shamir's Form 4 filing for IceCure Medical Ltd. (ICCM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Nov 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 25 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002046664 Primary reporting owner

Shamir Eyal

Relationship
Chief Executive Officer, Director
Address
7 HA'ESHEL ST., PO BOX 3163, CAESAREA, ISRAEL
Signature
/s/ Eyal Shamir
Signature date
02 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ICCM transaction

Ordinary Shares

Award

Transaction value
Shares
+404,901
Change %
+1535%
Price
$0.000000*
Shares after
431,281
Date
02 Nov 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents 404,901 restricted share units ("RSUs") granted on August 11, 2026, 25% of which vest on August 11, 2027 and the remaining 75% of which vest in twelve equal quarterly installments of 6.25% thereafter.

Footnote F2

Represents (i) 2,596 ordinary shares and (ii) 428,685 RSUs (including the RSUs described in Footnote 1 above), of which 9,862 have vested and 418,823 remain unvested as of November 2, 2026. The holdings in clauses (i) and (ii) have been adjusted to reflect the Issuer's 1-for-30 reverse share split effected on June 4, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .